Sodium Valproate in pharma franchise in Odisha

Sodium Valproate in PCD pharma franchise in Meghalaya

Sodium Valproate in top pharma company in Kohima

Sodium Valproate in pcd pharma supplier in Jodhpur

Sodium Valproate in phama franchise company in India
Sodium Valproate in phama distributor in Ludhiana

Home/Products /sodium-valproate-333mg-valporic-acid-145mg-tablet-tablet

Valpotime CR 500

Composition : Sodium Valproate (333mg) + Valproic Acid (145mg) Tablet

Dosage Form : Tablet

Packaging Type : Strip Pack

Packaging : 10*10

Price : ₹99/-

Valpotime CR 500 Tablet is a controlled-release formulation containing Sodium Valproate (333mg) and Valproic Acid (145mg), designed for the management of epilepsy and bipolar disorder. This medication works by stabilizing electrical activity in the brain, which helps prevent seizures and mood swings. The controlled-release mechanism ensures a slow and consistent release of the active ingredients over an extended period, improving the effectiveness of the treatment while reducing the likelihood of side effects.

Valpotime CR 500 is specifically formulated for long-term use, providing better seizure control and mood stabilization throughout the day. It is effective for generalized seizures, focal seizures, and mania associated with bipolar disorder, offering a convenient once-daily dosing regimen. The extended-release properties of the tablet allow for steady therapeutic effects, helping patients maintain a more consistent drug level in their system.

This combination is especially beneficial for individuals requiring long-term management, as it ensures a steady release of medication without the need for frequent dosing.

Read More

About the Product

Valpotime CR 500 Tablet is a controlled-release formulation containing Sodium Valproate (333mg) and Valproic Acid (145mg), designed for the management of epilepsy and bipolar disorder. This medication works by stabilizing electrical activity in the brain, which helps prevent seizures and mood swings. The controlled-release mechanism ensures a slow and consistent release of the active ingredients over an extended period, improving the effectiveness of the treatment while reducing the likelihood of side effects.

Valpotime CR 500 is specifically formulated for long-term use, providing better seizure control and mood stabilization throughout the day. It is effective for generalized seizures, focal seizures, and mania associated with bipolar disorder, offering a convenient once-daily dosing regimen. The extended-release properties of the tablet allow for steady therapeutic effects, helping patients maintain a more consistent drug level in their system.

This combination is especially beneficial for individuals requiring long-term management, as it ensures a steady release of medication without the need for frequent dosing.

Common side effects include dizziness, nausea, tremors, weight gain, and hair loss. Serious side effects may include liver problems, blood disorders, or pancreatitis.

Used for the treatment of epilepsy (generalized and focal seizures) and bipolar disorder (mania).

Consult a healthcare professional before use if you have liver disease, are pregnant, or are breastfeeding. Regular blood tests are recommended during treatment.

Store in a cool, dry place away from sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation